Firm announced it is doubling its ephedrine and pseudoephedrine production capacities from 350 to 700 metric tons per year at a cost of $10 mil. Knoll said new pl'ants are expected to be completed in 1987.
You may also be interested in...
Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.
based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.
Pink Sheet reporters and editors discuss their take-aways from the recent advisory committee meeting on coronavirus vaccine development and approval, as well as the upcoming FDA hearing on Makena’s withdrawal.